The adaptive immune system is a force inside your body so powerful it’s able to detect disease and fight it, often before you even realize that you’re sick.
Adaptive Biotechnologies is harnessing this vast system of biology to unleash its power as a natural diagnostic and therapeutic tool to propel a paradigm shift in medicine.
Monitoring adoptive cell therapy using immunosequencing
Monitoring adoptive cell therapy using immunosequencing Date: Thursday, April 28th 2022Time: 8am Los Angeles, 10am Chicago, 11am New York, 4pm London, 5pm Berlin Adoptive cellular and CAR-T immunotherapies have the potential to revolutionize the treatment of patients with various solid tumors and blood cancers, where patients’ T cells are extracted, modified and reinfused. As this…
Accelerating discovery with the immunoSEQ® HLA Classifier
Accelerating discovery with the immunoSEQ® HLA Classifier Thursday, March 17th 2022 8am Los Angeles, 10am Chicago, 11am New York, 3pm London, 4pm Berlin Classic major histocompatibility complex (MHC) proteins, also known as human leukocyte antigen proteins (HLA) in humans, play an essential role in immune function and regulation, including influencing the composition of the T-cell…
Impact of CMV infection on the T-cell repertoire
Impact of CMV infection on the T-cell repertoire:Insights from the immunoSEQ Assay In this webinar, you will discover: How the immunoSEQ® Assay has been used to gain mechanistic insights into the effects of CMV infection on T cells; Insights into the age-related impact of CMV infection on the T-cell repertoire, effect of CMV status of…
Unraveling the role of the adaptive immune system in autoimmune disease
Unraveling the role of the adaptive immune system in autoimmune disease On Demand Webinar In this webinar, you will discover: An overview of Adaptive Biotechnologies’ immunoSEQ® Assay and how immunosequencing can be used to understand the immunological mechanisms of autoimmune disease; More about applications of the immunoSEQ Technology for sequencing T-cell and B-cell receptors (TCRs…
-
SARS-CoV-2 variants are escaping neutralizing antibody responses, but have not escaped the T-cell response
SARS-CoV-2 variants are escaping neutralizing antibody responses, but have not escaped the T-cell response A Johnson & Johnson Case Study Available On-Demand To understand immune evasion of emerging variants and vaccine responses, researchers need to go beyond the antibody response and study the T-cell immune response to SARS-CoV-2. T cells generate immune responses to various…
-
Got FFPE? Immunosequencing with unique & challenging sample types
Got FFPE? Immunosequencing with unique & challenging sample types On Demand Webinar In this webinar, you will discover: An overview of the immunoSEQ® Technology and how its quantitative nature makes it uniquely suited to answer questions across numerous research areas; How to design successful and meaningful immunosequencing research projects with considerations for sample source and…
A role for autoimmunity in Parkinson’s Disease
On Demand Webinar In this webinar, you will discover: An overview of the immunoSEQ® Technology and how its quantitative nature enables accurate identification of disease-associated TCRB clones in response to antigen stimulation; How to confidently compare individual repertoires to identify public and private clones; Applications of immunosequencing to understand the role of T cells in…
Transgenic T-Cell Receptor Adoptive Cell Therapies: Addressing Epigenetic Suppression & Optimizing Therapies with Immunosequencing
On Demand Webinar In this webinar, you’ll discover: the principles of Adaptive Biotechnologies’ immunoSEQ Assay and how its quantitative and scalable nature makes it uniquely suited to answer questions related to immuno-oncology; how clone tracking, repertoire properties, and T-cell fraction have been used to better understand T-cell therapy research in oncology; how the immunoSEQ Assay…
From Bench to Biomarker: Applications of the immunoSEQ® Assay Across the Clinical Development Pipeline
On Demand Webinar Immunosequencing, the science of profiling T- and B-cell receptors, has broad utility across the clinical development spectrum. Adaptive Biotechnologies’ quantitative immunoSEQ® Technology can answer early, preclinical questions about drug candidate selection, dosing, and effective drug combinations. At the clinical trial stage, the immunoSEQ Assay can also help to confirm drug safety and…
Approaches to V(D)J Sequencing
On Demand Webinar In this webinar, you will discover: the evolution of V(D)J and CDR3 sequencing approaches and differences in the technologies used for V(D)J sequencing; an overview of the current capabilities of large-scale immunosequencing of T- and B-cell receptors; the principles and applications of Adaptive Biotechnologies’ quantitative immunoSEQ® Technology and how it can address…
COVID-19 Emerging themes: T-cell immune responses & immunoSEQ T-MAP COVID applications
On Demand Webinar At the beginning of 2020, few would have predicted that a global pandemic would turn our daily lives upside down. But 1 year later, the research community may have a clearer view of what might lie ahead. Throughout 2020, Adaptive Biotechnologies, along with researchers and collaborators around the world, contributed to the…
